For the last couple of weeks, I’ve noticed regular half-page ads from Seniors4BetterCare.com asking us to contact our ...

In Q2, it brought in $11.3 billion in sales, 36% higher than a year prior, and it cranked up its annual revenue guidance for ...

Roche is narrowing its pipeline to 11 disease areas and continuing to invest in a targeted way, said Teresa Graham, chief ...

Among biopharma firms, size didn’t always correlate with the highest wages, a recently debuted analysis of ‘best’ pharma ...

Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million ...

Mankind Pharma Ltd.’s board approved issuing Non-Convertible Debentures and Commercial Papers to raise up to ₹10,000 Crore, ...

As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.

Mankind Pharma plans to raise up to Rs 10,000 crore through non-convertible debentures and commercial papers. The board ...

With bipartisan support for price reductions, the upcoming election could reshape the future of prescription drug pricing in ...

Mankind Pharma will issue non-convertible debentures (NCDs) and commercial papers (CP) worth ₹5,000 crore. These funds will ...

Piramal Pharma Solutions invests $80 million in Lexington facility expansion to meet growing demand in injectables market.

Novartis shares have risen over 20% in the past 6 months, making it the best-performing global pharmaceutical stock. Find out ...